Single and Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of NM-101
Clinical trial NCT05790382 · UNKNOWN
Trial details
- NCT number
- NCT05790382
- Sponsor
- Neuramedy Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2024-05-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.